Replies to post #10681 on Genta, Inc (fka GNTAQ)

[The Holder]

vawedo...

...there was an appeal of that report. It appears the EMEA asked for an additional clinical trial, which Genta is giving them with the Agenda Trial.

http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=/www/story/07-19-2007/0004629263&EDATE